HP and cancer: In cancer, the altered glycosylation of Hp is manifested at different levels such fucosylation (the addition of fucose residues to an underlying glycan), sialylation (the addition of sialic acid residues to an underlying glycan), branching, and the presence of so-called Lewis antigens (glycan structures with fucose attached to an N-acetyllactosamine core) [40].